Cookie policy notice

By continuing to use this site you agree to our cookies policy below:
Since 26 May 2011, the law now states that cookies on websites can ony be used with your specific consent. Cookies allow us to ensure that you enjoy the best browsing experience.

This site is intended for health professionals only

At the heart of general practice since 1960

Lung cancer guidelines are inadequate for GPs

Studies funded by pharmaceutical companies do appear to be biased to company products, according to new research.

An analysis of studies presented at a medical conference found those sponsored by industry were significantly more likely to report in favour of a company product than those with other funding sources.

Of the 48 studies analysed, 30 were funded by pharmaceutical companies and 18 had no financial links.

All of those with ties to industry reported positive results but only two-thirds of those without links.

The findings were published in the American Journal of Medicine (December).

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say